Page last updated: 2024-10-21

homovanillic acid and Nervous System Diseases

homovanillic acid has been researched along with Nervous System Diseases in 38 studies

Homovanillic Acid: A 3-O-methyl ETHER of (3,4-dihydroxyphenyl)acetic acid.
homovanillate : A hydroxy monocarboxylic acid anion which is obtained by deprotonation of the carboxy group of homovanillic acid.
homovanillic acid : A monocarboxylic acid that is the 3-O-methyl ether of (3,4-dihydroxyphenyl)acetic acid. It is a catecholamine metabolite.

Nervous System Diseases: Diseases of the central and peripheral nervous system. This includes disorders of the brain, spinal cord, cranial nerves, peripheral nerves, nerve roots, autonomic nervous system, neuromuscular junction, and muscle.

Research Excerpts

ExcerptRelevanceReference
" In this study we explored the relationship between aggressiveness (as measured by the Overt Aggression Scale), cognitive performance (as measured by the Mini Mental State Examination), and biochemical markers of dopamine neurotransmission (homovanillic acid, HVA) and nitric oxide synthesis (nitrite plus nitrate, NO(x)) in cerebrospinal fluid from 70 patients with acute brain disorders, mainly brain infections."3.76Imbalance between nitric oxide and dopamine may underly aggression in acute neurological patients. ( Abundes-Corona, A; Montes, S; Nente, F; Perez-Neri, I; Ramirez-Abascal, M; Ramírez-Bermudez, J; Rios, C; Soto-Hernandez, JL, 2010)
"Maturation of monoamine neuronal systems was studied by measuring cerebrospinal fluid metabolites of dopamine (homovanillic acid) and serotonin (5-hydroxyindoleacetic acid) in 38 children with epilepsy and other neurological disorders, to whom probenecid had previously been administered."3.66Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders. ( Bowers, MB; Cohen, DJ; Leckman, JF; Shaywitz, BA; Young, JG, 1980)
"A prospective clinical and biochemical study on the effects of treatment with haloperidol has been performed in seven patients with Tourette syndrome."3.66Dopaminergic dsyfunction in Tourette syndrome. ( Butler, IJ; Coyle, JT; Seifert, WE; Singer, HS; Tune, LE, 1982)
"Sixteen patients with chronic congestive heart failure (CHF) and 6 patients with pure autonomic failure (PAF) were also studied to investigate possible effects of sympathetic nervous system overactivity and underactivity on peripheral HVA production and plasma HVA concentration."1.29Regional homovanillic acid production in humans. ( Eisenhofer, G; Esler, MD; Jennings, GL; Lambert, GW, 1993)
" Although not statistically significant, the VMA excretion was also noted to be moderately elevated; however, it is recognized that the present study was unable to establish a highly significant dose-response relationship between lead exposure and HVA excretion, as has been reported earlier in lead-poisoned children."1.28Neurochemical effect of lead exposure: a study on catecholamine metabolism. ( Chia, KS; Koh, D; Ong, CN; Saijoh, K, 1989)
"The striatal concentration of dopamine (DA), norepinephrine (NE), and homovanillic acid (HVA) was assessed in adult male rabbits exposed to styrene vapours or dosed with mandelic acid (MA), phenylglyoxylic acid (PGA) and phenylglycine (PG)."1.27Styrene metabolism and striatal dopamine depletion in rabbits. ( Falzoi, M; Franchini, I; Lucertini, S; Mutti, A; Romanelli, A, 1985)

Research

Studies (38)

TimeframeStudies, this research(%)All Research%
pre-199022 (57.89)18.7374
1990's8 (21.05)18.2507
2000's2 (5.26)29.6817
2010's4 (10.53)24.3611
2020's2 (5.26)2.80

Authors

AuthorsStudies
Vilanakis, E3
Papakonstantinou, E3
Paramera, E3
Argyri, I3
Drakou, E3
Kokkinou, E3
Zouvelou, V3
Outsika, C3
Pons, R4
Grabska-Kobylecka, I1
Kaczmarek-Bak, J1
Figlus, M1
Prymont-Przyminska, A1
Zwolinska, A1
Sarniak, A1
Wlodarczyk, A1
Glabinski, A1
Nowak, D1
Molero-Luis, M1
Serrano, M2
Ormazábal, A2
Pérez-Dueñas, B2
García-Cazorla, A2
Artuch, R1
Kurian, MA1
Ramírez-Bermudez, J1
Perez-Neri, I1
Montes, S1
Ramirez-Abascal, M1
Nente, F1
Abundes-Corona, A1
Soto-Hernandez, JL1
Rios, C1
Shi, X1
Zhang, L1
Fu, S1
Li, N1
González, V1
Pineda, M1
Fernández-Alvarez, E1
Campistol, JM1
Artuch, RM1
Bottiglieri, T1
Lim, CK1
Peters, TJ1
Shaywitz, BA1
Cohen, DJ1
Leckman, JF1
Young, JG1
Bowers, MB1
Van Woert, MH1
Magnussen, I1
Lowe, YH1
Hwang, EC1
Singer, HS1
Butler, IJ1
Tune, LE1
Seifert, WE1
Coyle, JT1
Gagnieu, MC1
Menouni-Foray, V1
Guardiola, P1
Quincy, C1
Renaud, B1
Hornykiewicz, O1
Shekim, WO1
Daniel, AE1
Koresko, RL1
Dekirmenjian, H1
Candito, M1
Nagatsu, T1
Chambon, P1
Chatel, M1
Vizuete, ML1
Steffen, V1
Machado, A1
Cano, J1
Oishi, T1
Hasegawa, E1
Murai, Y1
Lambert, GW1
Eisenhofer, G1
Jennings, GL1
Esler, MD1
Wakata, N1
Araki, Y1
Sugimoto, H1
Iguchi, H1
Kinoshita, M1
Moskowitz, MA2
Wurtman, RJ2
Askenasy, JJ1
Samuel, D1
Streifler, M1
Christie, DL1
Knauss, TA1
Zeman, J1
Böswart, J1
Davis, BA1
Durden, DA1
O'Reilly, RL1
Naudin, B1
Saligaut, C1
Costentin, J1
Carr, LA1
Rowell, PP1
Ichikawa, N1
Fuller, RW1
Hemrick-Luecke, SK1
Scheinin, M1
Ong, CN1
Chia, KS1
Koh, D1
Saijoh, K1
Hippius, H1
Ackenheil, M1
Müller-Spahn, F1
Mutti, A1
Romanelli, A1
Falzoi, M1
Lucertini, S1
Franchini, I1
Corsini, GU1
Pintus, S1
Chiueh, CC1
Weiss, JF1
Kopin, IJ1
Youngster, SK1
Sonsalla, PK1
Heikkila, RE2
Curzon, G1
Mrochek, JE1
Dinsmore, SR1
Ohrt, DW1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
[NCT00004325]200 participants Observational1988-12-31Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

3 reviews available for homovanillic acid and Nervous System Diseases

ArticleYear
Catecholamines and neurologic diseases (second of two parts).
    The New England journal of medicine, 1975, Aug-14, Volume: 293, Issue:7

    Topics: Animals; Attention Deficit Disorder with Hyperactivity; Brain; Brain Diseases; Catecholamines; Cereb

1975
Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Medical biology, 1985, Volume: 63, Issue:1

    Topics: Animals; Antidepressive Agents; Antipsychotic Agents; Biogenic Amines; Brain Diseases; Glycols; Homo

1985
Neuroendocrinological and biochemical effects of chronic neuroleptic treatment.
    Advances in biochemical psychopharmacology, 1985, Volume: 40

    Topics: Adult; Antipsychotic Agents; Apomorphine; beta-Endorphin; Drug Tolerance; Endocrine System Diseases;

1985

Other Studies

35 other studies available for homovanillic acid and Nervous System Diseases

ArticleYear
Cerebrospinal Fluid Concentrations of Neurotransmitters in a Greek Pediatric Reference Population.
    Neuropediatrics, 2023, Volume: 54, Issue:2

    Topics: Biogenic Amines; Child; Greece; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Nervous

2023
Cerebrospinal Fluid Concentrations of Neurotransmitters in a Greek Pediatric Reference Population.
    Neuropediatrics, 2023, Volume: 54, Issue:2

    Topics: Biogenic Amines; Child; Greece; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Nervous

2023
Cerebrospinal Fluid Concentrations of Neurotransmitters in a Greek Pediatric Reference Population.
    Neuropediatrics, 2023, Volume: 54, Issue:2

    Topics: Biogenic Amines; Child; Greece; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Nervous

2023
Cerebrospinal Fluid Concentrations of Neurotransmitters in a Greek Pediatric Reference Population.
    Neuropediatrics, 2023, Volume: 54, Issue:2

    Topics: Biogenic Amines; Child; Greece; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; Nervous

2023
The Presence of Caffeic Acid in Cerebrospinal Fluid: Evidence That Dietary Polyphenols Can Cross the Blood-Brain Barrier in Humans.
    Nutrients, 2020, May-25, Volume: 12, Issue:5

    Topics: Adult; Blood-Brain Barrier; Caffeic Acids; Chromatography, High Pressure Liquid; Diet, Western; Fema

2020
Homovanillic acid in cerebrospinal fluid of 1388 children with neurological disorders.
    Developmental medicine and child neurology, 2013, Volume: 55, Issue:6

    Topics: Adolescent; Algorithms; Asphyxia Neonatorum; Brain; Central Nervous System Infections; Child; Child,

2013
What is the role of dopamine in childhood neurological disorders?
    Developmental medicine and child neurology, 2013, Volume: 55, Issue:6

    Topics: Female; Homovanillic Acid; Humans; Male; Nervous System Diseases

2013
Imbalance between nitric oxide and dopamine may underly aggression in acute neurological patients.
    Neurochemical research, 2010, Volume: 35, Issue:10

    Topics: Acute Disease; Adult; Aggression; Cognition; Dopamine; Female; Homovanillic Acid; Humans; Male; Nerv

2010
Co-involvement of psychological and neurological abnormalities in infertility with polycystic ovarian syndrome.
    Archives of gynecology and obstetrics, 2011, Volume: 284, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Anxiety; Checklist; Depression; Diagnostic Self Evaluation; Dopamine

2011
Secondary abnormalities of neurotransmitters in infants with neurological disorders.
    Developmental medicine and child neurology, 2007, Volume: 49, Issue:10

    Topics: 5-Hydroxytryptophan; Atrophy; Brain; Electroencephalography; Epilepsy; Female; Homovanillic Acid; Hu

2007
Isocratic analysis of 3-methoxy-4-hydroxyphenyl glycol, 5-hydroxyindole-3-acetic acid and 4-hydroxy-3-methoxyphenylacetic acid in cerebrospinal fluid by high-performance liquid chromatography with amperometric detection.
    Journal of chromatography, 1984, Nov-28, Volume: 311, Issue:2

    Topics: Buffers; Chromatography, High Pressure Liquid; Depressive Disorder; Glycols; Homovanillic Acid; Huma

1984
Ontogeny of dopamine and serotonin metabolites in the cerebrospinal fluid of children with neurological disorders.
    Developmental medicine and child neurology, 1980, Volume: 22, Issue:6

    Topics: Adolescent; Child; Child, Preschool; Dopamine; Epilepsy; Female; Homovanillic Acid; Humans; Hydroxyi

1980
Study of serotonin in neuropsychiatric disorders.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 1982, Volume: 30, Issue:8

    Topics: 5-Hydroxytryptophan; Carbidopa; Female; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Kinetic

1982
Dopaminergic dsyfunction in Tourette syndrome.
    Annals of neurology, 1982, Volume: 12, Issue:4

    Topics: Adolescent; Dopamine; Female; Haloperidol; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male

1982
Liquid chromatographic determination of homovanillic acid, 5-hydroxyindoleacetic acid and probenecid levels in human cerebrospinal fluid during probenecid test.
    Clinica chimica acta; international journal of clinical chemistry, 1984, May-16, Volume: 139, Issue:1

    Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Electrochemistry; Homovanillic Acid; Humans

1984
Imbalance of brain monoamines and clinical disorders.
    Progress in brain research, 1982, Volume: 55

    Topics: Biogenic Amines; Brain; Depressive Disorder; Dopamine; Homovanillic Acid; Humans; Nervous System Dis

1982
Catecholamine metabolites in congenital sensory neuropathy with anhydrosis.
    Pediatrics, 1980, Volume: 65, Issue:1

    Topics: Body Temperature Regulation; Catecholamines; Child; Homovanillic Acid; Humans; Hyperkinesis; Hypesth

1980
High-performance liquid chromatographic measurement of cerebrospinal fluid tetrahydrobiopterin, neopterin, homovanillic acid and 5-hydroxindoleacetic acid in neurological diseases.
    Journal of chromatography. B, Biomedical applications, 1994, Jul-01, Volume: 657, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adult; Aged; Aged, 80 and over; Biopterins; Chromatography, High

1994
1-Methyl-4-phenylpyridinium has greater neurotoxic effect after selenium deficiency than after vitamin E deficiency in rat striatum.
    European journal of pharmacology, 1994, Apr-04, Volume: 270, Issue:2-3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Body Weight; Dopamine; Eating; Free Radicals; Glutathione P

1994
Sulfhydryl drugs reduce neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the mouse.
    Journal of neural transmission. Parkinson's disease and dementia section, 1993, Volume: 6, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striat

1993
Regional homovanillic acid production in humans.
    Life sciences, 1993, Volume: 53, Issue:1

    Topics: Adolescent; Adult; Aged; Autonomic Nervous System; Central Nervous System; Heart Failure; Hemodynami

1993
IDPN-induced monoamine and hydroxyl radical changes in the rat brain.
    Neurochemical research, 2000, Volume: 25, Issue:3

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Monoamines; Brain; Dopamine; Homovanillic Acid; Hy

2000
Catecholamines and neurologic diseases (first of two parts).
    The New England journal of medicine, 1975, Aug-07, Volume: 293, Issue:6

    Topics: Animals; Brain; Catecholamines; Cerebrospinal Fluid; Disease Models, Animal; Homovanillic Acid; Huma

1975
A new approach to the study of neurological diseases using stable isotopes.
    Israel journal of medical sciences, 1977, Volume: 13, Issue:12

    Topics: Animals; Biogenic Amines; Brain Chemistry; Gas Chromatography-Mass Spectrometry; Haplorhini; Homovan

1977
Gastrointestinal manifestations of "acquired dysautonomic" syndrome.
    The Journal of pediatrics, 1979, Volume: 94, Issue:4

    Topics: Autonomic Nervous System; Child, Preschool; Diarrhea; Esophagogastric Junction; Esophagus; Female; G

1979
[Metabolites of neurotransmitters in the cerebrospinal fluid in children].
    Ceskoslovenska pediatrie, 1991, Volume: 46, Issue:5

    Topics: Adolescent; Child; Child, Preschool; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Infant; In

1991
The effect of age, sex, weight and height on the plasma concentrations in healthy subjects of the acidic metabolites of some biogenic monoamines involved in psychiatric and neurological disorders.
    Progress in neuro-psychopharmacology & biological psychiatry, 1991, Volume: 15, Issue:4

    Topics: Adult; Aged; Aging; Biogenic Monoamines; Body Height; Body Weight; Female; Homovanillic Acid; Humans

1991
Influence of oxygen availability on the neurotoxic effect of 6-hydroxydopamine on nigro-striatal dopaminergic neurons.
    Neuroscience letters, 1991, Sep-02, Volume: 130, Issue:1

    Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Atmospheric Pressure; Chromatography, High Pressure Liquid;

1991
Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity by tobacco smoke.
    Neuropharmacology, 1990, Volume: 29, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striat

1990
Study on monoamine metabolite contents of cerebrospinal fluid in patients with neurodegenerative diseases.
    The Tohoku journal of experimental medicine, 1986, Volume: 150, Issue:4

    Topics: Adult; Aged; Female; Glycols; Homovanillic Acid; Humans; Hydroxyindoleacetic Acid; Male; Methoxyhydr

1986
A high dose of MPTP overcomes the protective effect of selegiline against dopaminergic neurotoxicity.
    The Journal of pharmacy and pharmacology, 1989, Volume: 41, Issue:7

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Corpus Striat

1989
Neurochemical effect of lead exposure: a study on catecholamine metabolism.
    American journal of industrial medicine, 1989, Volume: 16, Issue:6

    Topics: Adult; Cross-Sectional Studies; Female; Homovanillic Acid; Humans; Lead Poisoning; Male; Middle Aged

1989
Styrene metabolism and striatal dopamine depletion in rabbits.
    Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement, 1985, Volume: 8

    Topics: Animals; Corpus Striatum; Dopamine; Glycine; Glyoxylates; Homovanillic Acid; Male; Mandelic Acids; N

1985
1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity in mice is enhanced by pretreatment with diethyldithiocarbamate.
    European journal of pharmacology, 1985, Dec-10, Volume: 119, Issue:1-2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Biogenic Amin

1985
Evaluation of the biological activity of several analogs of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Journal of neurochemistry, 1987, Volume: 48, Issue:3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain; Corpus

1987
Differential neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in Swiss-Webster mice from different sources.
    European journal of pharmacology, 1985, Oct-29, Volume: 117, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemist

1985
Involuntary movements other than Parkinsonism: biochemical aspects.
    Proceedings of the Royal Society of Medicine, 1973, Volume: 66, Issue:9

    Topics: Acute Disease; Animals; Athetosis; Basal Ganglia; Brain; Dopamine; Fecal Incontinence; Homovanillic

1973
Monitoring phenylalanine-tyrosine metabolism by high-resolution liquid chromatography of urine.
    Clinical chemistry, 1973, Volume: 19, Issue:8

    Topics: Aromatic Amino Acid Decarboxylase Inhibitors; Autistic Disorder; Carbidopa; Catechols; Child; Chroma

1973